Literature DB >> 21182940

Influence of polyunsaturated fatty acids on Cortisol transport through MDCK and MDCK-MDR1 cells as blood-brain barrier in vitro model.

C Navarro1, I González-Álvarez, M González-Álvarez, M Manku, V Merino, V G Casabó, M Bermejo.   

Abstract

Transport across the blood-brain barrier is a relevant factor in the pharmacological action of many drugs and endogenous substances whose action site is located in brain. An overactive P-gp has been suggested to be of relevance for the resistance of the HPA system to be suppressed by glucocorticoids, which is one of the best described biological abnormalities in certain types of depression. PUFA acids have shown clinical efficacy in depressed patients and the hypothesis is that these compounds are able to reduce HPA axis activity as this effect has been shown in animal models of depression. The objective of the present work was (1) to characterize Cortisol transport through MDCK and MDCK-MDR1 cell lines (as in vitro models of the BBB) to confirm its transport mechanism as substrate of P-gp and (2) to evaluate the effect of PUFA acids as enhancers of Cortisol transport in the BBB model and explore the enhancement mechanism. Transport studies of Cortisol were performed in both directions, from apical-to-basolateral and from basolateral-to-apical sides. The in vitro experiments showed that Cortisol transport is concentration dependent and it is affected by several transporters (absorption and secretion processes). The results indicate that PUFA acids increase Cortisol transport in the BBB models but not through the inhibition of P-gp efflux but thanks to membrane fluidification and some effect on tight junction integrity.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21182940     DOI: 10.1016/j.ejps.2010.12.005

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  6 in total

1.  Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery.

Authors:  Sneha A Kulkarni; Si-Shen Feng
Journal:  Pharm Res       Date:  2013-01-12       Impact factor: 4.200

Review 2.  Approaches for enhancing oral bioavailability of peptides and proteins.

Authors:  Jwala Renukuntla; Aswani Dutt Vadlapudi; Ashaben Patel; Sai H S Boddu; Ashim K Mitra
Journal:  Int J Pharm       Date:  2013-02-18       Impact factor: 5.875

3.  CNS delivery and pharmacokinetic evaluations of DALDA analgesic peptide analog administered in Nano-sized oil-in-water emulsion formulation.

Authors:  Lipa Shah; Florence Gattacceca; Mansoor M Amiji
Journal:  Pharm Res       Date:  2013-12-03       Impact factor: 4.200

4.  Lysolipid containing liposomes for transendothelial drug delivery.

Authors:  Tilen Koklic; Janez Trancar
Journal:  BMC Res Notes       Date:  2012-04-10

Review 5.  Omega-3 fatty acids and depression: scientific evidence and biological mechanisms.

Authors:  Giuseppe Grosso; Fabio Galvano; Stefano Marventano; Michele Malaguarnera; Claudio Bucolo; Filippo Drago; Filippo Caraci
Journal:  Oxid Med Cell Longev       Date:  2014-03-18       Impact factor: 6.543

6.  The Role of Nanoparticle in Brain Permeability: An in-vitro BBB Model.

Authors:  Niusha Nikandish; Leila Hosseinzadeh; Abbas Hemati Azandaryani; Katayoun Derakhshandeh
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.